HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Finbarr P M O'Harte Selected Research

gastric inhibitory polypeptide receptor

1/2022Dual-agonist incretin peptides from fish with potential for obesity-related Type 2 diabetes therapy - A review.
1/2020Blockade of gastric inhibitory polypeptide (GIP) action as a novel means of countering insulin resistance in the treatment of obesity-diabetes.
6/2007Antagonistic effects of two novel GIP analogs, (Hyp3)GIP and (Hyp3)GIPLys16PAL, on the biological actions of GIP and longer-term effects in diabetic ob/ob mice.
2/2007Metabolic effects of sub-chronic ablation of the incretin receptors by daily administration of (Pro3)GIP and exendin(9-39)amide in obese diabetic (ob/ob) mice.
7/2006Biological activity and antidiabetic potential of synthetic fragment peptides of glucose-dependent insulinotropic polypeptide, GIP(1-16) and (Pro3)GIP(1-16).
9/2005A novel, long-acting agonist of glucose-dependent insulinotropic polypeptide suitable for once-daily administration in type 2 diabetes.
10/2003Glucose-dependent insulinotropic polypeptide (GIP): anti-diabetic and anti-obesity potential?
2/2002Characterization of the cellular and metabolic effects of a novel enzyme-resistant antagonist of glucose-dependent insulinotropic polypeptide.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Finbarr P M O'Harte Research Topics

Disease

19Type 2 Diabetes Mellitus (MODY)
01/2022 - 02/2002
18Body Weight (Weight, Body)
08/2022 - 09/2004
17Insulin Resistance
08/2022 - 06/2003
16Obesity
08/2022 - 04/2002
2Glucose Intolerance
01/2022 - 02/2006
1Short Bowel Syndrome
01/2021
1Weight Loss (Weight Reduction)
01/2021
1Hyperglycemia
11/2020
1Acquired Immunodeficiency Syndrome (AIDS)
07/2007
1Overnutrition
10/2003

Drug/Important Bio-Agent (IBA)

22Glucose (Dextrose)FDA LinkGeneric
08/2022 - 02/2002
14Peptides (Polypeptides)IBA
08/2022 - 08/2003
13Insulin (Novolin)FDA Link
08/2022 - 04/2002
8gastric inhibitory polypeptide receptorIBA
01/2022 - 02/2002
6Glucagon (Glukagon)FDA Link
08/2022 - 12/2003
6Glucagon-Like Peptide 1 (GLP 1)IBA
08/2022 - 02/2007
4IncretinsIBA
01/2022 - 12/2003
4AmidesIBA
12/2020 - 01/2018
4Hormones (Hormone)IBA
01/2018 - 10/2003
4Fatty Acids (Saturated Fatty Acids)IBA
01/2018 - 09/2005
4Pro(3)- glucose-dependent insulinotropic polypeptideIBA
02/2007 - 02/2002
3Exenatide (Byetta)FDA Link
08/2022 - 01/2018
3apelin-13 peptideIBA
01/2020 - 12/2017
3ApelinIBA
01/2020 - 12/2017
3Triglycerides (Triacylglycerol)IBA
01/2018 - 10/2009
3Gastrointestinal Hormones (Hormones, Gastrointestinal)IBA
08/2013 - 09/2005
2Glucagon Receptors (Glucagon Receptor)IBA
08/2022 - 04/2014
2LipidsIBA
01/2020 - 01/2018
2Biological ProductsIBA
11/2014 - 08/2003
1semaglutideIBA
01/2022
1Glucagon-Like Peptide-1 ReceptorIBA
01/2022
1tirzepatideIBA
01/2022
1Fish ProteinsIBA
11/2020
1Hypoglycemic Agents (Hypoglycemics)IBA
01/2020
1LiraglutideFDA Link
01/2020
1AntibodiesIBA
01/2020
1Gastric Inhibitory Polypeptide (Glucose Dependent Insulinotropic Peptide)IBA
01/2020
1LDL CholesterolIBA
01/2018
1HDL CholesterolIBA
01/2018
1Blood Glucose (Blood Sugar)IBA
01/2018
1OxyntomodulinIBA
11/2014
1deshistidyl(1)-prolyl(4)-glutamyl(9)- glucagonIBA
10/2014
1Cholecystokinin (Pancreozymin)IBA
08/2013
1monomethoxypolyethylene glycol (MPEG)IBA
08/2013
1(pGlu-Gln)-CCK-8IBA
01/2013
1Nateglinide (Starlix)FDA LinkGeneric
12/2009
1Dipeptidyl-Peptidase IV InhibitorsIBA
07/2007
1SolutionsIBA
07/2007
1Hyp(3)-palmitoylLys(16)- glucose-dependent insulinotropic polypeptideIBA
06/2007
1Hyp(3)- glucose-dependent insulinotropic polypeptideIBA
06/2007
1exendin (9-39)IBA
02/2007
1Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
04/2006
1N-AcGIP(LysPAL37)IBA
04/2006
1PalmitatesIBA
02/2005
1Pharmaceutical PreparationsIBA
12/2004
1glycated insulinIBA
02/2003
1Ascorbic Acid (Vitamin C)FDA LinkGeneric
04/2002
1EnzymesIBA
02/2002

Therapy/Procedure

7Therapeutics
01/2022 - 10/2003
4Injections
01/2020 - 09/2005
1Intraperitoneal Injections
02/2006